TICKERNERD
Menu
HCAHCAHealthcare · Medical Care Facilities

HCA Stock Forecast: HCA Healthcare, Inc. Price Predictions for 2026-2027

Last close, 4 Sept 2026
$405
−1.03% on the day

The 25 Wall Street analysts covering HCA Healthcare, Inc. hold a median 12-month price target of $435 — +7.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 67 of 100 as at 5 Sept 2026 — in the upper half.

Market cap
$87.7B
Ticker Nerd rank
67 / 100
Median analyst target
$435
Analysts covering
25
Revenue$20.2B+8.7% y/y
Operating income$3.1B
Net income$1.9B
Free cash flow$1.1B
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−3.1%
1M
+1.1%
YTD
−12.9%
1Y
−0.9%
From 52W high
−25.4%
From 52W low
+12.3%
$361
$543
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

HCA stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores HCA Healthcare, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 5 Sept 2026
67 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Quality
91
Value
87
Volatility
85
Growth
78
Issuance
60
Accruals
51
Momentum
48
Revisions
42
Size
3

Quality (91): The business earns solid, repeatable profits on what it owns.

Revisions (42): Analysts have, on balance, been cutting their forecasts.

Size (3): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

HCA stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on HCA, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$350$400$450$500$550$600Oct 25Jan 26Apr 26Jul 26HCAHigh $579Median $435Low $380

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says25 analysts
14 Buy10 Hold1 Sell
Low $380Median $435High $579

The green dot is the last close — the median target sits +7.4% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 1 moved their price target up and 8 moved it down.

DateFirmActionRatingTarget
20 Aug 2026JP MorganMaintainsNeutral$490 → $425
3 Aug 2026Wells FargoMaintainsEqual-Weight—
3 Aug 2026Wells FargoMaintainsEqual-Weight$369 → $381
28 July 2026Goldman SachsMaintainsBuy—
28 July 2026Goldman SachsMaintainsBuy$558 → $485
28 July 2026MizuhoMaintainsOutperform$525 → $475
28 July 2026MizuhoMaintainsOutperform—
27 July 2026BairdMaintainsNeutral—
27 July 2026BairdMaintainsNeutral$396 → $393
27 July 2026BarclaysMaintainsEqual-Weight$402 → $387
27 July 2026BarclaysMaintainsEqual-Weight—
27 July 2026KeybancMaintainsOverweight—
27 July 2026KeybancMaintainsOverweight$475 → $435
27 July 2026Morgan StanleyMaintainsUnderweight$425 → $380
27 July 2026Morgan StanleyMaintainsUnderweight—
27 July 2026OppenheimerMaintainsOutperform$520 → $485
27 July 2026OppenheimerMaintainsOutperform—
27 July 2026RBC CapitalReiteratesOutperform$435
27 July 2026RBC CapitalReiteratesOutperform—
27 July 2026Truist SecuritiesMaintainsBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. HCA appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

HCA vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 4 Sept 2026, HCA Healthcare, Inc. returned −0.9% against +20.0% for the S&P 500, dividends included.

HCA vs S&P 500, last 12 monthsTotal return, rebased to 100
90100110120130Oct 25Jan 26Apr 26Jul 26HCAS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

HCA analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
−2.4%
Analysts raising
7
Analysts cutting
10
Fundamentals

HCA Healthcare, Inc. (HCA) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
13.6×

Cheaper than 50% of US stocks

Price / sales
1.1×

Cheaper than 68% of US stocks

Price / book
−27.5×

Cheaper than 99% of US stocks

EV / EBITDA
9.0×

Cheaper than 42% of US stocks

Growth & margins
Revenue growth (YoY)
8.7%

Higher than 48% of US stocks

Earnings growth (YoY)
2.8%

Higher than 39% of US stocks

Gross margin
44.8%

Higher than 56% of US stocks

Operating margin
15.2%

Higher than 73% of US stocks

Net margin
8.8%

Higher than 67% of US stocks

Returns & dividend
Return on equity
−244.8%

Higher than 6% of US stocks

Return on assets
12.3%

Higher than 95% of US stocks

Dividend yield
0.8%

Higher than 16% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

HCA Healthcare, Inc. (HCA) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • HCA Healthcare, Inc. has a market value of $87.7B and an enterprise value of $141.5B.

  • Revenue in the twelve months to 30 June 2026: $78.0B. The latest quarter grew 8.7% year on year.

  • Net income over the same four quarters: $7.9B, a 10.1% net margin.

  • Diluted earnings per share, trailing twelve months: $29.87.

  • Free cash flow in the twelve months to 30 June 2026: $6.0B.

  • HCA Healthcare, Inc. spent $8.7B on share buybacks and $682.0M on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 218.0M.

  • Trailing P/E: 13.6×; forward P/E: 12.6× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.77%, paying out 10% of earnings.

  • HCA Healthcare, Inc. employs 230,000 people — $339K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 8 Sept 2026

Data provided by Twelve Data

Peers

HCA vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Care Facilities
CompanyMarket capTKN rank
HCAHCA Healthcare, Inc.$87.7B
67
THCTenet Healthcare Corp.$21.3B
97
DVADaVita, Inc.$12.3B
89
EHCEncompass Health Corp.$12.1B
81
UHSUniversal Health Services, Inc.$10.0B
67
ENSGThe Ensign Group, Inc.$9.9B
65
CHEChemed Corp.$7.0B
90

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own HCA Healthcare, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest HCA news & analysis

Can Operational Resiliency Protect HCA's Long-Term Profitability?

Zacks Investment Research · 28 Aug 2026positive

A Zacks Investment Research article examines whether HCA Healthcare's operational resiliency program can protect its long-term profitability. The report notes the program is helping control costs amid payer pressures, which may support long-term profitability and EBITDA growth.

Why it matters — HCA watchers would care because the resiliency program's cost controls could help offset ongoing payer pressures and support the company's profitability and EBITDA trajectory.

HCA Healthcare, Inc. to Present at September Conferences

Business Wire · 20 Aug 2026neutral

HCA Healthcare, Inc. announced it is scheduled to present at the Wells Fargo Healthcare Conference on September 9, 2026, and the Jefferies Healthcare Conference on September 15, 2026. Live audio webcasts and related presentation materials will be made available in the Investor Relations section of the company's website.

Why it matters — The presentations give HCA watchers an opportunity to hear directly from the company's leadership at major industry investor conferences.

HCA workers push for higher pay and more staffing amid billions in profits: ‘I'm struggling'

The Guardian · 11 Aug 2026negative

Workers at HCA Healthcare, the largest for-profit hospital system in the US, are pushing for higher pay and increased staffing while the company reports $6.8bn in profits.

Why it matters — This highlights growing tension between HCA's strong financial performance and employee dissatisfaction, which could affect operations, labor relations, and the company's public image.

HCA Healthcare Announces Dr. Michael Schlosser as Executive Vice President and Chief Clinical Officer; Names Charles Gressle President of New Ambulatory Operations Group

Business Wire · 6 Aug 2026neutral

HCA Healthcare announced that Dr. Michael Schlosser, currently senior vice president and chief transformation officer, will become executive vice president and chief clinical officer effective Sept. 1, 2026, succeeding Dr. Michael Cuffe. Separately, Charles Gressle, president of the East Florida Division, will become president of the company's new Ambulatory Operations Group effective Sept. 1.

Why it matters — The appointments signal leadership changes in HCA's clinical leadership and a new organizational focus on ambulatory operations.

Jim Cramer Looked At This 'Not Great' Uranium Stock 'For Years'

Benzinga · 6 Aug 2026neutral

On CNBC's "Mad Money Lightning Round," Jim Cramer commented on Fortinet, Inc., saying he likes the company and that it is doing a good job. The segment also mentioned that Cramer had looked at a uranium stock "for years" that he described as "not great."

Why it matters — The news item does not mention HCA Healthcare or the healthcare sector, so it has no direct bearing on HCA watchers.

FAQ

Frequently asked questions about HCA stock

What is the HCA stock price forecast for 2026-2027?

The 25 Wall Street analysts covering HCA Healthcare, Inc. have a median 12-month price target of $435, with estimates ranging from $380 to $579. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is HCA stock a buy right now?

Of the 25 analysts covering HCA Healthcare, Inc., 14 rate it a Buy, 10 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks HCA Healthcare, Inc. 67 out of 100 across roughly 4,600 US stocks as at 5 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank HCA?

As at 5 Sept 2026, HCA Healthcare, Inc. ranks 67 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Quality (91 of 100).

Will HCA stock go up?

No one can know that. What the data says: the median 12-month target from 25 analysts implies +7.4% from the last close, and Ticker Nerd's factor model ranks HCA Healthcare, Inc. 67 out of 100 as at 5 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the HCA stock forecast for 2030?

No analyst covering HCA Healthcare, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for HCA are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $380 to $579 over the next 12 months.

How has HCA stock performed over the past year?

HCA Healthcare, Inc. returned -0.9% over the 12 months to 4 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does HCA Healthcare, Inc. do?

HCA Healthcare, Inc. is a healthcare services company that operates a broad network of hospitals, ambulatory surgery centers, freestanding emergency rooms, urgent care clinics, physician practices, diagnostic and imaging centers, rehabilitation facilities, and other care sites.

What is the latest news on HCA?

The most recent item we track (Zacks Investment Research, 28 Aug 2026): "Can Operational Resiliency Protect HCA's Long-Term Profitability?". A Zacks Investment Research article examines whether HCA Healthcare's operational resiliency program can protect its long-term profitability. The report notes the program is helping control costs amid payer pressures, which may support long-term profitability and EBITDA growth.

Company

About HCA Healthcare, Inc.

HCA Healthcare, Inc. is a healthcare services company that operates a broad network of hospitals, ambulatory surgery centers, freestanding emergency rooms, urgent care clinics, physician practices, diagnostic and imaging centers, rehabilitation facilities, and other care sites. The company serves patients across the United States and the United Kingdom, with a strong emphasis on general and acute care, outpatient services, and specialty care such as oncology and rehabilitation. HCA Healthcare also provides home health and hospice services in select markets, supporting care across multiple stages of treatment. As one of the largest private operators in the hospital sector, HCA Healthcare plays a central role in delivering integrated medical care through coordinated local facilities and physician relationships. Founded in 1968 and headquartered in Nashville, Tennessee, HCA Healthcare focuses on expanding access to community-based healthcare services through its diversified clinical network.

CEO Mr. Samuel N. Hazen · 230,000 employees · United States · https://www.hcahealthcare.com